Google Übersetzer
Telesis Bio Inc.
About
Telesis Bio Inc. (PINK:TBIO) — investor relations, events, news, and company updates on 6ix.
Latest News
May 28 2025
Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis
Mar 18 2025
Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis
Sep 10 2024
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
Financials
Revenue
$17.03 M
Market Cap
$97.67 K
EPS
-30.42